Evidence map›Paper›PMID 35582655›Full record

ArticleWorld journal of clinical oncology2022

Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysis.

Justine Perrin, Karim Farid, Hilde Van Parijs, Olena Gorobets, Vincent Vinh-Hung, Nam P Nguyen, Navid Djassemi, Mark De Ridder, Hendrik Everaert

Registry-linked trialOpen access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of clinical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01432002 (Application of 18F-[FDG] PET/CT to Simulation and Planning of Radiotherapy), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01432002 unknown statusnot on this map

Application of 18F-[FDG] PET/CT to Simulation and Planning of Radiotherapy (RT) for Breast Cancer. Definition of Target Volume for 3-D RT and for Partial Breast Irradiation (PBI) by IMRT Technique

TypeobservationalSponsorUniversity Hospital, GenevaRan2007 to 2023Enrolled60ConditionsBreast Neoplasm
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Justine PerrinNuclear Medicine, CHU de Martinique, Fort-de-France 97200, Martinique.
Karim FaridNuclear Medicine, CHU de Martinique, Fort-de-France 97200, Martinique.
Hilde Van ParijsDepartment of Radiotherapy, UZ Brussel, Brussels 1090, Belgium.
Olena GorobetsHead and Neck Surgery, CHU de Martinique, Fort-de-France 97200, Martinique.
Vincent Vinh-HungDepartment of Radiotherapy, UZ Brussel, Brussels 1090, Belgium.
Nam P NguyenDepartment of Radiation Oncology, Howard University, Washington, DC 20060, United States.
Navid DjassemiDepartment of Pediatry, Hackensack University Medical Center, Hackensack, NJ 07601, United States.
Mark De RidderDepartment of Radiotherapy, UZ Brussel, Brussels 1090, Belgium.
Hendrik EveraertDepartment of Nuclear Medicine, UZ Brussel, Brussels 1090, Belgium.
Howard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prognostic value of preoperative fluorine-18-fluorodeoxyglucose positron-emission tomography (

aimTo evaluate the OS predictive value of preoperative PET positivity after 15 years.

methodsWe performed a retrospective search of the Universitair Ziekenhuis Brussel patient database for nonmetastatic patients who underwent preoperative PET between 2002-2008. PET positivity was determined by anatomical region of interest (AROI) findings for breast and axillary, sternal, and distant sites. The prognostic role of PET was examined as a qualitative binary factor (positive

resultsPoor OS within the 15-year study period was predicted by PET-positive status for axillary (

conclusionPreoperative PET is valuable for prediction of long-term survival. Ipsilateral axillary SUVmax ratio over the uninvolved side represents a new prognostic finding that warrants further investigation.

Indexed as

Breast surgeryLong-term prognosisOverall survivalPositron-emission tomography scanPreoperative workupRestricted mean survival time

Identifiers

PMID35582655
PMCPMC9052070
OpenAlexW4224230823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.